Christian Mias Appointed as New CEO of SCHOTT Pharma

SCHOTT Pharma AG & Co. KGaA has announced the appointment of Christian Mias as the new Chief Executive Officer, effective May 1, 2026. Mias will succeed Andreas Reisse, who plans to retire at the end of April 2026. This decision was made by the Supervisory Board of SCHOTT Pharma Management AG. Christian Mias has been part of the SCHOTT Group since 2007, where he has held various management positions. Most recently, he was the Head of the Business Unit Electronic Packaging.

The transition denotes a significant change in leadership for SCHOTT Pharma, a company active on the SDAX and listed in major German markets such as Frankfurt and Berlin. The company has not disclosed further details regarding strategic shifts under Mias's leadership.